Cargando…

Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Background: Although the predominant airway inflammation in chronic obstructive pulmonary disease (COPD) is neutrophilic, approximately 20–40% of COPD patients present with eosinophilic airway inflammation. Compared with non-eosinophilic COPD patients, eosinophilic COPD patients are characterized by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chuchu, Wang, Yalei, Zhang, Meng, Su, Xiaojie, Lei, Ting, Yu, Haichuan, Liu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594629/ https://www.ncbi.nlm.nih.gov/pubmed/34795588 http://dx.doi.org/10.3389/fphar.2021.754268

Ejemplares similares

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
por: Yu, Haichuan, et al.
Publicado: (2022)

The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review
por: Patterson, Megan F, et al.
Publicado: (2015)

Effect of Omega-3 Fatty Acids on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yu, Haichuan, et al.
Publicado: (2021)

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
por: Pala, Daniele, et al.
Publicado: (2021)

Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report
por: Huguenot, Marc, et al.
Publicado: (2022)

Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report
por: Kagoshima, Hiroki, et al.
Publicado: (2020)

Efficacy and safety of three species of Rhodiola L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
por: Yu, Haichuan, et al.
Publicado: (2023)

Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports
por: Skouvaklidou, Elpida, et al.
Publicado: (2023)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
por: Frohberger, Stefan J., et al.
Publicado: (2019)

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
Publicado: (1988)

Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthma
por: Drick, Nora, et al.
Publicado: (2023)

Comparison of IL-33 and IL-5 family mediated activation of human eosinophils
por: Angulo, Evelyn L., et al.
Publicado: (2019)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Mouse resident lung eosinophils are dependent on IL‐5
por: Dolitzky, Avishay, et al.
Publicado: (2022)

Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis
por: Li, Qian, et al.
Publicado: (2022)

IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients
por: Kubota, Kazunori, et al.
Publicado: (2017)

Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
por: Liu, Meiling, et al.
Publicado: (2021)

Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs
por: Patial, Sonika, et al.
Publicado: (2021)

Efficacy of Vitamin C Supplementation on Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
por: Lei, Ting, et al.
Publicado: (2022)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
por: Yu, Weiwei, et al.
Publicado: (2021)

Effects of Dexmedetomidine on Postoperative Delirium and Expression of IL-1β, IL-6, and TNF-α in Elderly Patients After Hip Fracture Operation
por: Zhang, Wenchao, et al.
Publicado: (2020)

AIM2 Inflammasome Activation Leads to IL-1α and TGF-β Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells
por: Colarusso, Chiara, et al.
Publicado: (2019)

Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation
por: Chou, Chun-Chi, et al.
Publicado: (2022)

Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils
Publicado: (1996)

Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration
por: Li, Yanning, et al.
Publicado: (2017)

Pin1 Regulates IL-5 Induced Eosinophil Polarization and Migration
por: Shen, Zhong-Jian, et al.
Publicado: (2021)

EOSINOPHILS AND IL-5 RECEPTOR IN COVID-19 POSTMORTEM LUNG TISSUE
por: MCCRAE, CHRISTOPHER, et al.
Publicado: (2021)

Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU
por: Barbarot, Nicolas, et al.
Publicado: (2022)

Platinum Accumulation and Cancer-Related Fatigue, Correlation With IL-8, TNF-α and Hemocytes
por: Zhang, Yuling, et al.
Publicado: (2021)

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis
por: Silvagni, Ettore, et al.
Publicado: (2021)

Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies
por: Jaén, Marta, et al.
Publicado: (2021)

Sequential Biotherapy Targeting IL-5 and IL-4/13 in Patients with Eosinophilic Asthma with Sinusitis and Otitis Media
por: Chikumoto, Ayumi, et al.
Publicado: (2022)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)
por: Ahlberg, Jennifer, et al.
Publicado: (2019)

IL-9 neutralizing antibody suppresses allergic inflammation in ovalbumin-induced allergic rhinitis mouse model
por: Zhao, He, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a2dkm867v247ij4cm0t62tu8tn